Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

German approval for Ezetrol

Oct. 18, 2002

New zinc complexes with dual activity as insulin mimetics and antihypertensive agents

Oct. 18, 2002

LibiGel advances into phase II for FSD

Oct. 17, 2002

New agents for thrombocytopenia described by Yamanouchi

Oct. 17, 2002

Mechanism underlying contraceptive effect of ZK-137316 evaluated in monkeys

Oct. 16, 2002

Indications for Glucovance broadened by FDA

Oct. 16, 2002

Neurocrine Biosciences and Taisho restructure NBI-6024 agreement

Oct. 16, 2002

New inhibitors of advanced glycation end products reported by Meiji Seika

Oct. 16, 2002

Novel PPARalpha agonists under study at Pfizer

Oct. 16, 2002

Avandamet approved for type 2 diabetes

Oct. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...